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1. Introduction
   Monodora is a genus of plant in the family Annonaceae. It 
contains approximately 35 species, distributed throughout 
tropical Africa. Two of the species, Monodora myristica 
and Monodora tenuifolia (M. tenuifolia) are widely used as 
spices. M. tenuifolia is a plant with a rich ethnobotanical 
history. In traditional medicine practice, it is widely used 
to relieve toothache, dysentery, diarrhoea, dermatitis, 
headache, and as vermifuge[1]. M. tenuifolia is a spice that 
has been shown to possess potent antioxidant activity[2]. 
Therefore, it can be hypothesized to be effective in the 
management and treatment of diseases caused by oxidative 
stress. 
   Spices have enjoyed widespread use for the treatment 
of several ailments, but still little is known about their 
toxicity and safety issue which are always a concern. 
Investigations on spices provide evidence for the presence 
of substances that offer potential human health benefits. 
However, it should be a vital requirement to determine the 
toxic effects of some of the substances contained in these 
plants[3]. Toxicity is an expression of being poisonous, 
indicating the state of adverse effects led by the interaction 
between toxicants and cells[4]. This interaction may vary 
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depending on the chemical properties of the toxicants and 
the cell membrane, as it may occur on the cell surface, 
within the cell body, or in the tissues beneath as well as at 
the extra cellular matrix. The toxic effects may take place 
prior to the binding of the toxicants to the vital organs such 
as liver and kidneys. Hence, evaluation of toxic properties 
of a substance is crucial when considering for public health 
protection because exposure to chemicals can be hazardous 
and results to adverse effects on human being. In practice, 
the evaluation typically includes acute, subacute, chronic, 
carcinogenic and reproductive effects. The present study 
therefore aims at investigating the effects of the flavonoid 
rich fraction of M. tenuifolia seed on the haematology, 
histology and liver profile of Wistar albino rats as part of a 
wider study to evaluate the pharmacological potential of the 
seed, thereby evaluating its safety.      
2. Materials and methods
2.1. Plant materials
   Fresh seeds of M. tenuifolia (Figure 1) were obtained 
between the month of May and June, 2013 from fruits 
harvested from the plant growing within the University 
of Nigeria Nsukka, Enugu State. The fruits and hence the 
seeds were authenticated by a botanist in the Department 
of Botany, University of Nigeria through comparison with a 
voucher specimen present in the herbarium. 
Figure 1. M. tenuifolia seeds.
2.2. Experimental animals
   All the experimental animals used were obtained from the 
animal house of the Zoological Garden, University of Nigeria 
Nsukka. 
2.3. Preparation of M. tenuifolia seed flour
   The fresh seeds of M. tenuifolia were shade dried for 48 
h, then reduced in size to a coarse texture using a manual 
blender (Corona, Landers Colombia) and packed in airtight 
containers.
2.4. Extraction of flavonoid rich fractions
   The aqueous-alcoholic extract and fractions of ground 
M. tenuifolia seed was obtained by solvent-solvent 
extraction technique according to the method described 
by Harborne[5] with slight modifications. A quantity, 5.5 
kg ground seeds of M. tenuifolia was macerated twice 
with 10 L of 70% ethanol for 72 h at room temperature. The 
combined maceration was passed through Whatman No.4 
filter paper and mixed thoroughly with 1.8 L of chloroform 
to partition the aqueous-alcoholic extract. Two distinct 
layers were obtained, the upper aqueous layer and the 
lower chloroform layer. The two layers were drawn out 
separately and the chloroform fraction was dried in vacuo, 
weighed and called the chloroform fraction. A quantity, 
2.75 L of the main (aqueous portion) extract was extracted 
three times with an equal volume of ethyl acetate for 48 h at 
room temperature. The ethyl acetate soluble extracts were 
pulled together and dried in vacuo, weighed and called the 
ethyl acetate fraction. The remaining aqueous extracts were 
stored away. Then 11.6 g of the dried ethyl acetate fraction 
was suspended in a relatively small volume (200 mL) of 
absolute methanol and allowed to settle. The dissolved part 
was separated from the rest by filtration through Whatman 
No.4 filter paper and then concentrated in vacuo weighed 
and called methanol fraction. The total flavonoid content 
of the different fraction was determined quantitatively by 
spectrophotometer method.
2.5. Total flavonoid concentration of fractions
   The total flavonoid content of the fractional extracts and 
standard was determined according to the method of Chang 
et al[6]. 
2.6. Toxicity study (LD50) of the flavonoid rich fraction
   Acute toxicity study of the flavonoid rich fraction was 
carried out according to the method of Lorke[7] using 39 
albino mice of both sexes of average weight between 13.2-
19.2 g, that were dosed orally with different gradual doses 
(10-5 000 mg/kg body weight). In the first phase, mice were 
divided into three groups of nine mice each and were treated 
with the extract at doses of 10, 100 and 1 000 mg/kg body 
weight orally by means of a cannula. They were observed for 
24 h for signs of toxicity, mortality and general behaviours. 
In the second phase, twelve mice were divided into four 
groups of three mice each and were also administered with 
the flavonoid rich fraction at doses of 1 000, 1 600, 2 900, and 
5 000 mg/kg body weight orally. They were observed for 24 h 
for signs of toxicity, mortality and general behaviours. The 
LD50 was calculated as the geometric mean of the highest 
non-lethal dose (with no death) and the lowest lethal dose 
(where death occurred).
LD50=√minimum toxic dose伊maximum tolerated dose
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2.7. 14 and 28 d oral toxicity study on the flavonoid fraction 
2.7.1. Animal study
   Adult male Wistar rats of age 8 weeks were used for the 
subacute toxicity profiling. They were fed ad libitum with 
standard feed, and had free access to water. They were 
also maintained under standard conditions of humidity, 
temperature, and 12 h light/dark cycle. The animals were 
acclimatised for a week before the commencement of the 
study. A standard protocol was drawn up in accordance 
with current guidelines for the care for laboratory animals 
and ethical guidelines for investigations of experiments in 
conscious animals[8].
2.7.2. Dosing
   Twenty four albino rats of average weight between 95 to 
140 g were selected by stratified randomisation and then 
divided into four groups of six rats. Group I, Group II, and 
Group III were given 100, 200 and 400 mg/kg body weight 
respectively of the flavonoid rich fraction orally for 14 d and 
28 d respectively. One percent of DMSO served as the vehicle 
and was used to prepare the doses. Group IV served as the 
control group and received the diluted vehicle only. The first 
day of dosing was taken as Day 0 and blood was collected 
on Day 14 and 28 respectively and used for biochemical, 
haematological and histopathological analysis.   
2.7.3. Mortality and clinical signs (General behaviour)
   During the four-week dosing period, all the animals were 
observed daily for clinical signs and mortality patterns once 
before dosing, immediately after dosing and up to 2-4 h after 
dosing. 
2.7.4. Weekly body weight measurement
   The body weight of each rat was expressed using a 
sensitive balance during the acclimatisation period, once 
before commencement of dosing, once weekly during the 
period and once on the day of sacrifice.   
2.7.5. Determination of haematological parameters
   Blood samples were collected by the orbital technique. 
Blood sample for haematological determinations was 
collected from the retrobulbar plexus of the medial canthus 
of the eye to puncture the retrobulbar plexus and thus enable 
outflow of blood into a sample bottle containing EDTA. The 
sample bottle was shaken gently to mix up the blood with 
EDTA and prevent clothing. The values of the red blood cells 
(RBCs) count, total and differential white blood cells (WBCs) 
count, packed cell volume (PCV), erythrocyte sedimentation 
rate and haemoglobin (Hb) content were determined. 
The quantities of RBCs and WBCs were determined with 
the improved Neubauer Haemocytometre[9]. PCV was 
determined spectrophotometrically using the cyanomet 
haemoglobin method[10]. The erythrocyte sedimentation rate 
was determined by the method of Westergren as described 
by Mbaka et al[9]. All haematological parameters were 
determined at room temperature (27依0.5) °C.  
2.7.6. Determination of biochemical parameters
   Blood was collected by orbital technique. The blood 
sample was kept at room temperature for 30 min to clot. 
Afterwards, the test tube containing the clotted blood sample 
was centrifuged at 3 000 r/min for 10 min using a table 
centrifuge to enable a complete separation of the serum from 
the clotted blood. The clear serum supernatant was then 
carefully aspirated with syringe and needle and stored in a 
clean sample bottle for the biochemical tests. The values of 
blood glucose, total serum protein, serum albumin, serum 
cholesterol, serum alanine aminotransferase (ALT), serum 
aspartate aminotransferase (AST), serum alkaline phosphatase 
(ALP), serum urea and serum creatinine were determined 
following standard laboratory procedures. All haematological 
parameters were determined at room temperature (27.0依0.5) 
°C. 
2.7.7. Organ weight
   The liver, kidney and heart of rats in the various groups 
were excised on the Day 14 and 28 immediately after blood 
collection. Following excision, the organs were trimmed of 
extraneous tissues, placed on a saline soaked gauze pad to 
retard desiccation and were immediately weighed (paired 
organs were weighed together) to one decimal place and 
calculated for organ weight ratio[11].
Organ weight ratio =
Organ weight (g)
Body weight (g)
伊100 
2.7.8. Histopathological examination
   For postmortem, the rats in the various groups were 
dissected and careful examination of the liver was 
carried out. Tissue samples were fixed in 10% formalin 
and dehydrated overnight using upgraded ethanol series 
and embedded in paraffin blocks. Ultrathin sections 
were dewaxed by xylene, hydrated through a degraded 
ethanol series, and stained with haematoxylin and eosin. 
A pathologist, blinded to the treatments, performed the 
histopathologic examination with an optical microscope 
[Nikon Eclipse E600, USA (伊400)]. Sections were assigned 
grades as reported by Djami et al[12].
2.8. Statistical analysis
   Values of treated groups were compared statistically with 
control by Independent Sample t-test, One-way ANOVA and 
Spearman correlation. Inferences were made from findings at 
95% confidence level. Data obtained were presented as mean 
依standard deviation and analysed by simple percentages.
3. Results
   The effect of the flavonoid rich fraction of the aqueous alcoholic 
extract of the seed of M. tenuifolia was investigated on the 
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haematology, histopathology and liver profile of Wistar albino 
rats as part of a wider study to evaluate the pharmacological 
potential of the seed, thereby evaluating its safety.
3.1. Phytochemical study
3.1.1. Flavonoid determination
   Table 1 shows the result of the total flavonoid content of 
the chloroform fraction, ethyl acetate fraction and methanol 
fraction of the aqueous-alcoholic extract of M. tenuifolia 
seed. The total flavonoid content of chloroform fraction, ethyl 
acetate fraction and methanol fraction was found to be (12.10
依0.01) mg/g, (12.50依0.04) mg/g and (9.20依0.01) mg/g in terms of 
quercetin equivalent respectively.  
Table 1
Total flavonoid content of the different fractions.
Fractional extract Flavonoid content (mg/g)
Chloroform soluble extract 12.10依0.01
Ethyl acetate soluble extract 12.50依0.04
Methanol soluble extract  9.20依0.01
3.2. Toxicological testing
3.2.1. Acute toxicity assay
   Table 2 shows the result of the acute toxicity study (LD50) 
of the flavonoid rich fraction of M. tenuifolia seed. There 
was no sign of toxicity or mortality up to the dose of 1 000 
mg/kg. However, there was partial decrease in activity and 
increased respiratory rate in mice which lasted few minutes 
after administration of extract.  
Table 2
Acute toxicity study on the flavonoid rich ethyl acetate fraction.
Group
Number used/
mortality
General behaviour
Phase one
10 mg/kg 9/0 None observed
100 mg/kg 9/0 None observed
1000 mg/kg 9/0 None observed
Phase two
1 000 mg/kg 3/0 None observed
1 600 mg/kg 3/0 Partial hypo activity and increased respiratory rate
2 900 mg/kg 3/0 Partial hypo activity and initial increase in respiratory rate
5 000 mg/kg 3/0 Partial hypo activity and initial increase in respiratory rate
3.2.2. Mortality and clinical signs (general behaviour)
   Table 3 shows the effect of oral administration of the 
flavonoid rich fraction of M. tenuifolia seed on the general 
behaviour of the rats. There was no noticeable deviation in 
the behaviour of the rats treated with 100, 200 and 400 mg/kg 
compared to that of the control.
Table 3
Effect of subacute administration of flavonoid rich fraction of M. tenuifolia seed 
on the general behaviour of the rats.
Group/Dose (mg/kg)
Mortality and gross symptoms of toxicity in various groups of rats
Rats/
Doses
Sex
Dead/Total 
number
Mortality 
latency/Day
Initial symptom(s) of 
toxicity
Group I (Control) 6 Male 0/6 - None observed
Group II (100 mg/kg) 6 Male 0/6 - None observed
Group III (200 mg/kg) 6 Male 0/6 - None observed
Group IV (400 mg/kg) 6 Male 0/6 - None observed
Total 24
3.2.3. Body weight changes in rats
   Table 4 illustrates the effect of M. tenuifolia on the 
changes in bodyweight of rats over the dosing. Overall, the 
rats grew at rates of (2.13依0.04), (2.20依0.56), (2.11依0.24) and 
(2.22依0.23) g/d respectively for the control, 100, 200, and 400 
mg/kg dose groups respectively. After 28 d of exposure to 
M. tenuifolia, an increase in growth in all the groups was 
observed. The result suggested that the 28 d of subacute 
oral ingestion of M. tenuifolia did not affect the weight of 
rats. 
Table 4
The effect of M. tenuifolia on the changes in body weight of rats over 
the dosing period.
Days
Group I 
(Control)
Group II
(100 mg/kg)
Group III 
(200 mg/kg)
Group IV
(400 mg/kg)
Body weight of rats (g) (mean依SD) n=6
Day 0 118.17依12.48 118.44依14.71 124.38依9.60  127.61依11.47
Day 7 119.33依13.29 119.50依16.36 126.40依5.55 128.67依8.26
Day 14 125.17依12.70 125.83依14.85 132.40依4.92 134.83依7.63
Body weight of rats (g) (mean依SD) n=3
Day 21 164.00依10.00 149.33依31.39 172.00依16.97 178.00依3.46
Day 28 177.67依11.24 180.00依30.27 183.50依16.26 189.67依4.94
Growth rate per day  2.13依0.04   2.20依0.56   2.11依0.24    2.22依0.23
Values are represented as mean依SD of triplicates. 
3.2.4. Weight of organs
   Table 5 illustrates the organ weight and relative organ 
weight of rats. There was significant (P<0.05) increase in 
liver of rats in group IV treated with flavonoid rich fraction 
of the seed extract of M. tenuifolia after the Day 14 but 
no significant (P>0.05) difference was observed in liver of 
rats after the Day 28. No significant (P>0.05) difference was 
observed in kidney and heart for the groups treated with 
flavonoid rich fraction of M. tenuifolia after the Day 14 and 
28.  
3.2.5. Biochemical markers
   Table 6 shows the effect of the flavonoid rich fraction of 
M. tenuifolia seed on kidney function and liver function 
parameters. After the Day 14, AST was significantly (P<0.05) 
reduced in Group IV. There was also significant (P<0.05) 
decrease in ALT in Group II and III and a significant 
decrease (P<0.01) in Group IV. Alkaline phosphatase was 
markedly increased in the entire treated group but not 
significantly (P>0.05) different from the control. There was 
dose dependent decrease in total serum protein for all 
treated groups but not significantly (P>0.05) different from 
the control group. There was no statistically significant 
(P>0.05) difference in urea, creatinine, albumin and 
globulin. The ratio of albumin to globulin was elevated 
in all the treated groups but was not significantly (P<0.05) 
different from the control. After the Day 28, there was no 
significant (P>0.05) difference in AST, ALP, urea, creatinine, 
total protein, albumin and globulin in all the groups 
compared to the control. The ratio of albumin to globulin 
was not significantly (P>0.05) different in all treated groups 
compared to the control.
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Table 6
Levels of biochemical markers of kidney profile and liver profile in 
rats administered flavonoid rich fraction of M. tenuifolia.
Parameter
Group I 
(Control)
Group II (100 
mg/kg)
Group III 
(200 mg/kg)
Group IV 
(400 mg/kg)
Day 14, n=3
ALT (IU/L)  36.43依5.59   30.15依1.56a    26.98依3.23a   23.80依0.87b
AST (IU/L)    89.93依10.54  83.00依2.99   80.00依7.70   75.95依0.81a
ALP (IU/L) 175.93依4.98 171.72依7.36 176.53依2.06 178.76依7.63
Creatinine (mg/dL)    0.56依0.10    0.53依0.11    0.56依0.10    0.54依0.07
Urea (mg/dL)  23.73依8.30   22.95依5.99  27.88依6.65  22.60依7.64
Total protein (g/dL)    5.66依1.11    5.32依0.19    5.23依0.37   5.33依0.18
Albumin (g/dL)    2.79依0.11    2.67依0.10    2.71依0.10   2.75依0.13
Globulin (g/dL)    3.03依0.73    2.64依0.18    2.51依0.27   2.58依0.18
Albumin/Globulin    0.96依0.20    1.00依0.10    1.13依0.11  1.13依0.57
Day 28, n=3
ALT (IU/L)   24.90依1.88  25.67依2.39   21.48依0.42 23.66依1.10
AST (IU/L)   66.68依2.42  70.66依3.82   67.05依0.72 67.17依1.21
ALP (IU/L) 188.39依1.28 189.83依1.23 187.92依0.45 180.88依10.89
Creatinine (mg/dL)   0.51依0.03     0.57依0.05    0.49依0.07   0.50依0.05
Urea (mg/dl)  24.90依8.10   23.81依5.50   22.60依5.66 27.70依7.0
Total protein (g/dL)   5.67依0.36     6.03依0.37     5.75依0.17    6.29依0.25
Albumin (g/dL)   3.14依0.15     3.27依0.15     3.31依0.04    3.51依0.43
Globulin (g/dL)   2.50依0.90     2.75依0.46     2.44依0.13    2.77依0.21
Albumin/Globulin   1.23依0.11     1.20依0.20     1.35依0.07    1.20依0.10
Values are represented as mean依SD of triplicates. Values on the same 
row followed by superscript letters differ significantly (aP<0.05, bP<0.01) 
from the control. 
3.2.6. Haematological parameters 
   Table 7 shows the effect of flavonoid rich fraction of the 
seed extract of M. tenuifolia on haematological parameters 
in rats. After the Day 14, there was no significant (P>0.05) 
effect on total WBC in treated group compared to the control 
group. There was no significant (P>0.05) effect on the 
basophil, eosinophil, lymphocyte, monocyte and neutrophil 
count in the treated groups compared to the control group. 
RBC, Hb, erythrocyte sedimentation rats, and packed 
cell volume were not significantly different (P>0.05) in 
the test groups compared to the control group. There was 
also no significant (P>0.05) effect on mean corpuscular 
volume (MCV), mean corpuscular haemoglobin (MCH), mean 
corpuscular haemoglobin concentration (MCHC) in the treated 
groups compared with the control group. After the Day 28, 
packed cell volume and haemoglobin concentration were 
elevated significantly (P<0.05) in Group IV compared to the 
control group. Erythrocyte sedimentation rate was decreased 
significantly (P<0.05) in Group IV compared to the control 
group. There was an increase in RBC concentration but 
not significantly. However total WBC, basophil, eosinophil, 
lymphocyte, monocyte, neutrophil, MCV, MCH, MCHC were 
not significantly (P>0.05) affected in the treated groups 
compared to the control group.
Table 7
Levels of some haematological markers in rats on ethyl acetate seed 
extract of M. tenuifolia.
Parameter
Group I 
(Control)
Group II 
(100 mg/kg)
Group III 
(200 mg/kg)
Group IV 
(400 mg/kg)
Day 14, n=3
RBC (伊106/µL) 10.03依1.62   8.71依0.47  8.63依2.26  8.27依0.44
Haemoglobin (g/dL) 14.80依1.29 13.41依0.53 13.89依0.87 14.55依0.25
PCV (%) 43.00依2.64 42.73依0.25 42.80依2.02 42.00依2.00
ESR (mm/h)  1.10依0.26   0.96依0.20   1.10依0.10  1.06依0.30
TWBc (伊103/µL) 14.23依1.96 12.11依3.90 13.46依4.27 14.21依1.93
Basophil (伊103/µL) 0 0 0 0
Eosinophil (伊103/µL)   2.33依1.15   1.66依1.52   3.00依1.00  1.00依1.00
Lymphocyte (伊103/µL) 79.00依5.00 77.33依2.08 70.66依1.52 71.33依4.50
Monocyte (伊103/µL)   0.66依0.57   0.33依0.57   2.66依0.57  1.66依0.57
Neutrophil (伊103/µL) 18.33依3.51 20.66依1.52 23.66依2.88 26.00依4.35
MCV (fL) 43.47依6.09 49.08依3.42  51.32依10.18 51.77依1.97
MCH (pg) 14.80依1.29 13.11依0.53 13.89依0.87 14.55依0.25
MCHC (g/dL) 34.42依2.47 30.86依1.40 32.44依1.05 34.71依1.92
Day 28, n=3
RBC (伊106/µL) 9.09依0.58   8.60依0.55   9.67依1.42 9.20依1.87
Haemoglobin (g/dL) 14.08依1.62 14.59依1.44 15.53依0.23 15.93依0.54a
PCV (%) 39.16依2.84 40.83依2.84 43.00依2.12 43.06依3.21
a
ESR (mm/h)   1.13依0.41   0.93依0.49   0.75依0.07 0.70依0.10a
TWBc (伊103/µL) 15.51依4.09 15.33依4.33 11.27依2.08 18.06依3.35
Basophil (伊103/µL) 0 0 0 0
Eosinophil (伊103/µL)   1.33依0.57   1.66依0.57   2.00依1.41   2.33依1.52
Lymphocyte (伊103/µL) 79.33依2.30 81.66依1.52 81.50依3.53 79.66依2.51
Monocyte (伊103/µL)   1.00依1.00   0.68依0.57   0.50依0.70   1.33依1.15
Neutrophil (伊103/µL) 18.33依2.08 16.00依2.00 16.00依1.41 16.66依2.51
MCV (fL) 43.07依0.69 47.43依0.60 44.79依4.42 48.28依6.65
MCH (pg) 15.45依0.90 16.92依0.58 16.51依2.55 17.82依3.88
MCHC (g/dL) 34.20依3.32 35.69依1.35 36.76依2.09 36.67依4.01
Values are represented as mean依SD of triplicates. Values on the 
same row followed by superscript letters differ significantly (aP<0.05, 
bP<0.01) from the control. ESR: erythrocyte sedimentation rate.
Table 5
Organ weight and relative organ weight of rats in parenthesis.
Parameter Group I (Control) Group II (100 mg/kg) Group III (200 mg/kg) Group IV (400 mg/kg)
Day 14, n=3
Liver 3.55依0.99 [4.12依0.44] 3.66依1.80 [3.88依0.36] 4.77依0.80 [4.43依0.71]  5.61依0.38a [4.99依0.48] a
Kidney 1.05依0.48 [1.19依0.25] 1.05依0.14 [1.11依0.06] 1.18依0.98 [1.09依0.03] 1.26依0.10 [1.04依0.06]
Heart 0.48依0.16 [0.55依0.06] 0.55依0.10 [0.58依0.07] 0.62依0.03 [0.57依0.01] 0.52依0.81 [0.43依0.04]
Day 28, n=3
Liver 5.92依0.09 [4.47依0.30] 6.49依2.44 [4.65依0.80] 5.82依0.76 [4.17依0.18] 6.60依0.65 [4.41依0.63]
Kidney 1.42依0.03 [1.07依0.06] 1.47依0.48 [1.07依0.11] 1.47依0.06 [1.06依0.42] 1.59依0.13 [1.03依0.11]
Heart 0.62依0.06 [0.47依0.02] 0.70依0.12 [0.52依0.08] 0.74依0.07 [0.54依0.09] 0.77依0.15 [0.50依0.03]
Values are represented as mean依SD of triplicates. Values in parenthesis are % weight of organ with respect to the body weight of rats. Values on 
the same row followed by superscript letters differ significantly (aP<0.05) from the control. 
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3.2.7. Results of histopathological assessment of organs
   Figure 2 illustrates the photomicrograph of liver section 
from Group I (Control) rats showing normal portal area. There 
was no abnormal activity seen around the bile duct area 
and blood vessel after the Day 14 showing normal portal 
activity. Figure 3 and 4 illustrates the photomicrograph of 
liver section from rats given 100 mg/kg and 200 mg/kg of the 
flavonoid rich fraction of M. tenuifolia seed respectively 
showing peribiliary hepatitis. There was mobilisation of 
inflammatory cells around the bile duct area after the Day 
14 showing peribilliary hepatitis. Figure 5 illustrates the 
photomicrograph of liver section from rats given 400 mg/kg 
of the flavonoid rich fraction of M. tenuifolia seed showing 
portal hepatitis. There was mobilisation of inflammatory 
cells around the bile duct area and blood vessels after the 
Day 14 showing complete portal hepatitis. 
BV
Figure 2. Photomicrograph of liver section from Group I (Control) rats showing 
normal portal area. 
BV: blood vessel; Arrow: bile ducts. H and E伊40. 
BD
Figure 3. Photomicrograph of liver section from rats given 100 mg/kg of the 
flavonoid rich fraction of M. tenuifolia seed showing peribilliary hepatitis. 
Arrow: inflammatory cells; BD: bile duct. H and E 伊40. 
BD
Figure 4. Photomicrograph of liver section from rats given 200 mg/kg of the 
flavonoid rich fraction of M. tenuifolia seed showing peribilliary hepatitis. 
Arrows: inflammatory cells; BD: bile duct showing cholestasis. H and E 伊40.
BD
Figure 5. Photomicrograph of liver section from rats given 400 mg/kg of the 
flavonoid rich fraction of M. tenuifolia seed showing portal hepatitis. 
Arrow: inflammatory cells; BD: bile duct. H and E 伊40. 
4. Discussion
   To determine the safety of drugs and plants products 
for human use, toxicological evaluation is carried out in 
various experimental animals to predict toxicity and to 
provide guidelines for selecting a “safe” dose in humans. 
The highest overall concordances of toxicity in animals 
with humans are with haematological, gastrointestinal 
and cardiovascular adverse effects[13], with certain 
adverse effects in humans, especially hypersentivity 
and idiosyncratic reactions, and are poorly correlated 
with toxicity observed in animals. Furthermore, it is 
quite difficult to ascertain adverse effects in animals 
such as headache, abdominal pain, dizziness, and visual 
disturbances. In addition, interspecies differences in the 
pharmacokinetic parameters make it difficult to translate 
some adverse effects from animals to humans.
   Chloroform was the highest extracting solvent amongst 
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the other solvents because it generally extracted the highest 
quantity of plant material from the aqueous alcoholic 
extract compared to ethyl acetate. It shows that the seeds 
of M. tenuifolia contain more nonpolar material than polar 
material since chloroform extracted the highest quantity 
of plant material. The total flavonoid content of chloroform 
fraction, ethyl acetate fraction and methanol fraction was 
found to be (12.10依0.01) mg/g, (12.50依0.04) mg/g and (9.20依
0.01) mg/g in terms of quercetin equivalent respectively. 
The ethyl acetate fraction had the highest content of 
total flavonoid and was used as the flavonoid fraction in 
subsequent animal studies.
   Acute toxicity tests are generally the first test conducted 
in any toxicity study. They provide data on the relative 
toxicity likely to arise from a single brief exposure to any 
substance. Different plants extracts have been known to 
possess different levels of bioactive compounds inherent 
in the plants[14]. In the acute toxicity study, flavonoid 
rich fraction of M. tenuifolia seed extract did not show 
any mortality up to the dose of 5 000 mg/kg during the 
observational period of 48 h. However, minor changes in 
behaviour, breathing, and activity were observed in mice 
administered 1 600, 2 900 and 5 000 mg/kg of the fraction few 
minutes after administration. These results showed that in 
single dose, there was no adverse effect of flavonoid rich 
fraction of M. tenuifolia seed extract, indicating that the 
LD50 is higher than 5 000 mg/kg for both male and female 
mice. Accordingly, about one-twelfth of the maximum 
tolerated dose, that is, 400 mg/kg was considered as the 
high dose of the flavonoid rich fraction of M. tenuifolia seed 
extract and used for the subsequent animal studies.
   A summary of the results of the mortality and gross 
symptoms of toxicity seen in rats administered orally with 
the flavonoid rich fraction of M. tenuifolia seed extract 
over 28 d. Firstly, there was no noticeable deviation in the 
behaviour of the rats administered orally with 100, 200, 
and 400 mg/kg compared to that of the control (Group I, no 
dose) group and essentially all the dosed rats remained 
healthy during the 28 d period of oral administration of 
the flavonoid fraction of M. tenuifolia seed. Moreover, no 
deaths occurred with any of the doses up to 400 mg/kg given 
over 28 d confirming that the LD50 for subacute dosing with 
flavonoid rich fraction of M. tenuifolia seed was higher than 
400 mg/kg. 
   Changes in the body weight have been used as an 
indicator of adverse effects of drugs and chemicals[15]. There 
was slight increase in weight at the onset of the 28 d study 
which peaked subsequently suggesting that the extract 
does not exert any deteriorative effect on the weight and 
growth of the animals. The increase in weight of the animals 
suggests that they increasingly accumulated calories from 
the normal rat diet. Although the animals used in this study 
were fed with normal rat diet, the M. tenuifolia seed extract 
might have allowed proper absorption and utilisation of 
the nutrients. Low level of active/toxic principles may have 
stimulated appetite and increased feed utilization resulting 
in increased weight gain. The seed of M. tenuifolia is used as 
a spice[1]. There have not been any reported cases of toxicity 
in humans.
   Organ weight is also an important index of physiological 
and pathological status in animals. The relative organ weight 
is fundamental to establish whether the organ was exposed 
to the injury or not. The heart, liver, kidney, spleen, and 
lungs are the primary organs affected by metabolic reaction 
caused by toxicant[16]. The liver, being a key organ in the 
metabolism and detoxification of xenobiotics, is vulnerable 
to damage induced by a huge variety of chemicals[16]. Thus, 
the observed significant (P<0.05) increase in liver weight of 
the group administered orally with 400 mg/kg body weight 
of the flavonoid rich fraction after the Day 14 could be 
attributed to high rate of metabolism of the liver resulting 
from the brief exposure to extract (containing several 
constituents).
   Analysis of blood parameters is relevant to risk evaluation 
and the changes in the haematological system have a 
higher predictive value for human toxicity, when the data 
are translated from animal studies[17]. The assessment of 
haematological parameters could be used to reveal the 
deleterious effect of foreign compounds including plant 
extract on the blood constituents of animals. They can also 
be used to determine possible alterations in the levels of 
bio molecules, metabolic products, haematology, normal 
functioning and histomorphology of the organs[16]. The 
increase in erythrocytes (RBC), PCV, MCH, MCHC, MCV and 
Hb after the 28 day study may be due to over production 
of haematopoietic regulatory elements such as colony-
stimulating factors, erythropoietin and thrombopoietin by the 
stroma cells and macrophages in the bone marrow[18] thus 
providing the local environment for haematopoiesis[18]. Since 
MCHC, MCH and MCV relate to individual RBCs, while Hb, RBC 
and PCV relate to the total population of RBCs in the blood[19], 
it could encourage haemoglobin incorporation into RBCs and 
a consequent increase in oxygen exchange. MCV reflects the 
size of RBCs. The MCH and MCHC reflect the haemoglobin 
content of RBCs.
   Urea and creatinine are considered as a suitable 
prognostic indicator of renal dysfunction and kidney failure 
for any toxic compounds[20]. In this study, the absence of 
significant differences in these parameters after the Day 14 
and the Day 28 means that M. tenuifolia seed extract has no 
harmful effect on the kidney.
   The evaluation of adverse effects of subacute oral 
dosing based on biochemical and histological analysis in 
experimental animal may be more relevant in determining 
the overall toxicity of the flavonoid rich fraction of M. 
tenuifolia seed extract. When liver cell plasma membrane 
is damaged, a variety of enzymes normally located in the 
cytosol are released into the blood stream. Measurements 
of the activities of serum marker enzymes like ALT, AST and 
ALP have provided a powerful tool for the assessment of liver 
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function[21]. The reduction in the levels of AST and ALT by 
the flavonoid rich fraction of M. tenuifolia after the Day 14 
is an indication of stabilisation of the integrity of the cell 
membrane of the hepatocytes, keeping the membrane intact 
and the enzyme enclosed. ALT is a cytosolic enzyme found 
in very high concentration in the liver[21], and an increase of 
this specific enzyme indicates hepatocellular damage, while 
AST is less specific than ALT as an indicator of liver function.
   Alkaline phosphatase is membrane bound and its 
alteration is likely to affect the membrane permeability 
and produce derangement in the transport of metabolites. 
There was increase but not significantly in the level of 
alkaline phosphate after the Day 14. A rise in serum ALP 
level is usually a characteristic finding in cholestatic liver 
disease[22,23]. No significant effect was noticed after the Day 
28. An elevated serum ALP level is often associated with 
various disorders such as extrahepatic bile obstruction, 
intrahepatic cholestasis, infiltrative liver disease, as well as 
hepatitis and bone disease[16].
   Histopathology of the liver sections of the control rats 
showed normal hepatic architecture and normal liver lobular 
structure with well-preserved cytoplasm, prominent nucleus 
and nucleolus. The effect of the flavonoid rich fraction of M. 
tenuifolia on the liver was confirmed from histopathological 
sectioning which indicated various degrees of peribiliary 
hepatitis in Group II (100 mg/kg), Group III (200 mg/kg) and 
Group IV (400 mg/kg) rats due to obstruction of bile flow in 
the liver after the Day 14. These changes also confirms that 
the significant increases in ALP and liver weight observed 
within the groups administered 100, 200 and 400 mg/kg of the 
flavonoid rich fraction after the Day 14 due to hepatobilliary 
obstruction leading to cholestasis.
   Cholestasis, extrahepatic or intrahepatic, is a common 
pathophysiological process in many human diseases leading 
to the accumulation of toxic bile salts within the liver[24]. It 
is known that increased concentration of bile acids induce 
lipid peroxides, probably related to the stimulation of 
phagocytic activity in the polymorphonuclear leucocytes 
and inflammatory cells, which are present after biliary tract 
obstruction and enhance the tissue injury[24,25]. 
   Cholestasis (lack of bile flow) results from the blockage of 
bile ducts or from a disease that impairs bile formation in 
the liver itself. Alkaline phosphatase level typically rises 
to several times the normal level after several days of bile 
duct obstruction or intra-hepatic cholestasis[26]. The results 
obtained in this study clearly show that the medicinal 
plant examined exerted an initial effect on bile production 
and/or flow, the fact that the serum ALP, very low density 
lipoprotein and triacylglycerol levels eventually normalised 
after the Day 28 implies that the bile obstruction and/or 
impairment of liver bile synthesis, was a temporary event 
that fizzled out. From the results obtained in this study, 
flavonoid rich fraction of M. tenuifolia seed appears to be 
practically safe when administered acutely to mice through 
the oral route. When administered orally to rats for Day 14 
and 28 toxicity study, the flavonoid rich fraction was found 
to have a membrane stabilizing effect on the hepatocytes, 
the flavonoid rich fraction did not have any deleterious 
effect on the haematopoietic system, serum ALP significantly 
increased after the Day 14. However, it normalised after 
the Day 28. The histopathological examination of the liver 
section showed various degrees of peribiliary obstruction 
after the Day 14 which normalised after the Day 28. The 
result therefore suggests that the seed extract was potentially 
safe for consumption orally. The result therefore suggests 
that the seed extract was potentially safe for consumption 
orally.
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Comments 
Background
   The World Health Organization encourages the use of 
plants for the treatment of health problems particularly in 
developing countries. Recent findings have shown that many 
of these medicinal plants are potentially toxic, mutagenic 
and carcinogenic. The present study evaluated some of such 
information and confirms the safety of traditional use of M. 
tenuifolia seed.
  
Research frontiers
   The present research work describes in vivo acute and 
subacute oral toxicity study on the flavonoid rich fraction of 
M. tenuifolia seed in rodent assessed by estimating mortality 
rate, body and vital organs weights change and evaluating 
kidney and liver biomarkers and hematological markers and 
the effect of extract on liver at graded concentrations. 
Related reports
   Several works were reported in the literature on this plant 
species as biopesticide, antidiarrheal. This is the first time 
report on the pharmacological potential of the flavonoid rich 
fraction of M. tenuifolia seed on the haematology, histology 
and liver profile of Wistar albino rats. 
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Innovations and breakthroughs
   M. tenuifolia seeds are widely used in Western Africa 
to treat various ailments including toothache, dysentery, 
diarrhoea, dermatitis, headache, etc. In the present study, 
authors provide consistent evidence of the safety of this 
plant species in rodent model. 
  
Applications
   The pharmaceutical relevance of findings from this study 
derives from the possibility of formulating the flavonoid 
rich fraction of M. tenuifolia as phytomecines to be used in 
Africa (where plants have constituted the basis of traditional 
medicine systems for thousands of years) as well as in other 
parts of the world.
Peer review
   This is an interesting study in which authors have 
demonstrated the safety of M. tenuifolia in rodent. 
Toxicological bioassays were assessed based on biochemical 
and hematological parameters, and histopathological 
observations. Flavonoid rich fraction of M. tenuifolia 
seeds were found to be no toxic and could be served as 
nutraceuticals.  
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